Healthcare & Life Sciences Transactions
News & Insights for Public Companies
- Kirkland Advises Phibro Animal Health on Acquisition of Assets from Zoetis
- Kirkland Represents GL Capital on Proposed Privatization of SciClone Pharmaceuticals
- Kirkland Advises Ingersoll Rand on $2.325 Billion Acquisition of ILC Dover
- Kirkland Advises AbbVie on $8.7 Billion Acquisition of Cerevel Therapeutics
- Kirkland Advises Bristol Myers Squibb on Acquisition of Mirati Therapeutics for up to $5.8 Billion
- Kirkland Advises Eli Lilly on $1.4 Billion Acquisition of POINT Biopharma
- Kirkland Advises Eli Lilly on Acquisition of DICE Therapeutics
- Kirkland Advises Option Care Health in Merger with Amedisys
- Kirkland Represents Eli Lilly on Divesture of BAQSIMI to Amphastar